"Androstadienes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
| Descriptor ID |
D000730
|
| MeSH Number(s) |
D04.210.500.054.079.129
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Androstadienes".
Below are MeSH descriptors whose meaning is more specific than "Androstadienes".
This graph shows the total number of publications written about "Androstadienes" by people in this website by year, and whether "Androstadienes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 3 | 2 | 5 |
| 2018 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Androstadienes" by people in Profiles.
-
COVID-19-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2021 07; 46(5):927-929.
-
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial). COPD. 2018 Jun-Aug; 15(4):334-340.
-
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting ß2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial. Respir Med. 2018 08; 141:111-120.
-
Juglone induces apoptosis and autophagy via modulation of mitogen-activated protein kinase pathways in human hepatocellular carcinoma cells. Food Chem Toxicol. 2018 Jun; 116(Pt B):40-50.
-
COPD 2017: A Year in Review. COPD. 2018 04; 15(2):118-122.
-
Glucocorticoid Receptor Nuclear Translocation in CD4 T Cells from Severe and Moderate Asthmatic Patients Treated with Fluticasone/Vilanterol. Iran J Allergy Asthma Immunol. 2018 Feb; 17(1):1-8.
-
Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent? Int J Chron Obstruct Pulmon Dis. 2017; 12:3425-3427.
-
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2017 12; 11(12):955-967.
-
Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozole. Anticancer Drugs. 2017 09; 28(8):931-933.
-
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial. J Eval Clin Pract. 2018 02; 24(1):258-261.